GL1X · GenesisL1 explorer

MolNFT v1 · #112131 · protein

Crystal structure of equine serum albumin in complex with diclofenac and naproxen

4ZBR: “Crystal structure of equine serum albumin in complex with diclofenac and naproxen”. X-ray diffraction, 3 ligands (NPS, LMR, DIF), 8 pockets (best druggability 0.81). MolNFT v1 #112131 on GenesisL1: 3D structure, binding sites and…

PDB
4ZBR
Type
protein
Length
580 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Serum albumin
UniProt
F7BAY6
Ligands
NPS, LMR, DIF
Pockets
8 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 74% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerum albuminprotein58074% helix, 0% strandF7BAY6

Ligands and binding sites

  • NPS · (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid · ligand · 2 copies · chains A
  • LMR · (2S)-2-hydroxybutanedioic acid · ligand · 2 copies · chains A
  • DIF · 2-[2,6-dichlorophenyl)amino]benzeneacetic acid · ligand · chains A
  • ACT · Acetate ion · additive · 2 copies · chains A
  • FMT · Formic acid · additive · 2 copies · chains A
  • SIN · Succinic acid · additive · chains A
  • MLI · Malonate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15250.810.8765SIN, LMR
27830.790.8256LMR, ACT, FMT
32520.680.8441DIF, NPS
42280.600.8025NPS, MLI
5580.580.9021FMT

Modifications

Observed in the structure: 17 disulfide (disulfide).

Compared structures

  • 4ZBR · Crystal Structure of Equine Serum Albumin in complex with Diclofenac and Naproxen · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.